BCAX

Bicara Therapeutics
BCAX

Overview Fund Trends Analyst Outlook Journalist POV
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$38
108% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
HC Wainwright & Co
HC Wainwright & Co
Robert Burns
40% 1-yr BCAX win rate
22 Aug ‘25 1 month ago
Piper Sandler
Piper Sandler
Kelsey Goodwin
100% 1-yr BCAX win rate
19 Aug ‘25 2 months ago